Labcorp (LH) legal chief Kathryn Kyle discloses stock and RSU holdings

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Kathryn W. Kyle, EVP and Chief Legal Officer, reports her beneficial ownership of company securities. She directly holds 3,052.4574 shares of Labcorp common stock. In addition, she holds several grants of Restricted Stock Units (RSUs), each representing the contingent right to receive one share of Labcorp common stock.

The RSUs cover 178 shares vesting on February 7, 2026; 360 shares vesting in two equal installments on February 6, 2026 and February 6, 2027; 650 shares vesting in three equal annual installments beginning on February 11, 2026; and 770 shares vesting in three equal annual installments beginning on July 1, 2026. All holdings are reported as directly owned.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kyle Kathryn W

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/04/2026

3. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Legal Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3,052.4574	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	(1)	Common Stock	178	(2)	D
Restricted Stock Unit	(3)	(3)	Common Stock	360	(2)	D
Restricted Stock Unit	(4)	(4)	Common Stock	650	(2)	D
Restricted Stock Unit	(5)	(5)	Common Stock	770	(2)	D

Explanation of Responses:

1. The Restricted Stock Units vest on February 7, 2026.

2. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

3. The Restricted Stock Units vest in two equal installments on February 6, 2026 and February 6, 2027.

4. The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.

5. The Restricted Stock Units vest in three equal annual installments beginning on July 1, 2026.

	/s/ Kathryn W. Kyle	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the reporting person in Labcorp (LH)'s Form 3?

The reporting person is Kathryn W. Kyle, who serves as EVP, Chief Legal Officer of Labcorp Holdings Inc. She is not listed as a director or 10% owner.

How many Labcorp (LH) common shares does Kathryn W. Kyle beneficially own?

Kathryn W. Kyle reports beneficial ownership of 3,052.4574 shares of Labcorp common stock, held in direct ownership form.

What Restricted Stock Units (RSUs) are reported in this Labcorp (LH) Form 3?

The Form 3 lists four RSU awards tied to Labcorp common stock: 178, 360, 650, and 770 RSUs, each reported as directly owned.

When do the Labcorp (LH) RSUs reported by Kathryn W. Kyle vest?

The RSUs vest as follows: 178 units on February 7, 2026; 360 units in two equal installments on February 6, 2026 and February 6, 2027; 650 units in three equal annual installments beginning February 11, 2026; and 770 units in three equal annual installments beginning July 1, 2026.

What does each Labcorp (LH) Restricted Stock Unit represent in this Form 3?

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. common stock, subject to the vesting schedule described.

Are Kathryn W. Kyle’s Labcorp (LH) holdings reported as direct or indirect ownership?

All reported positions—both common stock and Restricted Stock Units—are listed with an ownership form of Direct (D), with no indirect ownership noted.